Senior Director, Biostatistics

The Senior Director, Biostatistics will serve as the Biostatistics lead for several Immunovant’s development programs. In this role, you will be collaborating with both internal and external stakeholders to deliver the tactical execution of our Biostatistics strategy. The individual in this position will have the unique opportunity to participate in the rapid growth of a biotech startup.

• →Provide oversight and contributions to statistics strategy, planning, execution, and communication for programs as assigned.
• →Provide scientifically rigorous statistical input into clinical development plans, protocol development, statistical analysis plans, regulatory submissions and questions, interpretation of statistical analysis results, and other product support initiatives.
• →Develop effective collaborations with others within clinical teams and partner lines (such as Medical Directors and Regulatory).
• →Ensure that all study and project level statistical activities are conducted in compliance with relevant regulatory requirements and Immunovant standards.
• →Identify opportunities to utilize innovative statistical methodology to streamline the clinical development process and facilitate optimal decision-making.
• →Manage indication/study biostatisticians.

• PhD. in Statistic, Biostatistics, Mathematics or related field
• 12+ years of experience in biotechnology, pharmaceutical or health related area
• Knowledge of relevant Health Authority and ICH guidelines, as well as regulations
• Demonstrated experience in engaging with Health Authorities
• Comprehensive understanding of drug development from Phase 2 to launch
• Demonstrated ability to collaborate with diverse sets of stakeholders
• Strong written and oral communication skills with attention to detail
• Desire to work in a fast-paced, innovative environment
• Natural collaborator who enjoys working on a cross-functional team

• Remote-based
• Dynamic, interactive, fast-paced, and entrepreneurial environment
• Domestic or international travel are required (<10%)